{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T19:18:17Z","timestamp":1770232697857,"version":"3.49.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:p>\n                    Gallbladder neuroendocrine tumors (GB-NETs) are rare, accounting for &lt;0.5% of all NETs, and little is known about somatostatin receptor expression (SSTR) and its response to SSTR-targeted treatment such as Lutetium-177 (\n                    <jats:sup>177<\/jats:sup>\n                    Lu) DOTATATE.\n                    <jats:sup>68<\/jats:sup>\n                    Ga DOTATATE PET\/CT is a valuable imaging modality for SSTR expression and\n                    <jats:sup>177<\/jats:sup>\n                    Lu DOTATATE treatment planning. We present a case of a 74-year-old man with recurrent WHO grade 3 GB-NET.\n                    <jats:sup>177<\/jats:sup>\n                    Lu DOTATATE failed to control hepatic metastases despite high DOTATATE uptake, which led to treatment discontinuation. This case highlights the fact that positive SSTR imaging in GB-NETs does not always lead to a favorable response to\n                    <jats:sup>177<\/jats:sup>\n                    Lu DOTATATE.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006001","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T16:06:22Z","timestamp":1749139582000},"page":"e190-e192","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Gallbladder Neuroendocrine Tumor and 177Lu DOTATATE: High Somatostatin Receptor Expression Without Clinical Response"],"prefix":"10.1097","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2381-2058","authenticated-orcid":false,"given":"Mehmet","family":"Aksakal","sequence":"first","affiliation":[{"name":"Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Liu","sequence":"additional","affiliation":[{"name":"Laboratory Medicine and Pathology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine L.","family":"Chen","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gentry","family":"King","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Iravani","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"R1-20260203","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1245\/s10434-019-07440-6","article-title":"Primary gallbladder neuroendocrine tumors: insights into a rare histology using a large national database","volume":"26","author":"Ayabe","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R3-20260203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00259-011-2039-y","article-title":"Lutetium-labelled peptides for therapy of neuroendocrine tumours","volume":"39","author":"Kam","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R4-20260203","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00259-019-04439-9","article-title":"Prognostic significance of somatostatin receptor heterogeneity in progressive neuroendocrine tumor treated with Lu-177 DOTATOC or Lu-177 DOTATATE","volume":"47","author":"Graf","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-20260203","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2214\/AJR.18.19881","article-title":"Neuroendocrine tumor diagnosis and management: 68Ga-DOTATATE PET\/CT","volume":"211","author":"Sanli","year":"2018","journal-title":"Am J Roentgenol"},{"key":"R6-20260203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPA.0000000000000949","article-title":"The role of 68Ga-DOTATATE positron emission tomography\/computed tomography in well-differentiated neuroendocrine tumors: a case-based approach illustrates potential benefits and challenges","volume":"47","author":"Raj","year":"2018","journal-title":"Pancreas"},{"key":"R7-20260203","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1161\/STROKEAHA.112.662692","article-title":"Clinical and histological significance of gadolinium enhancement in carotid atherosclerotic plaque","volume":"43","author":"Millon","year":"2012","journal-title":"Stroke"},{"key":"R8-20260203","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00259-018-3967-6","article-title":"PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy","volume":"45","author":"Bodei","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-20260203","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1097\/RLU.0000000000005539","article-title":"Hepatic recurrence of neuroendocrine tumor component in gallbladder cancer","volume":"50","author":"Ikejiri","year":"2025","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:00:40Z","timestamp":1770141640000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006001","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"2025-03-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}